- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02179307
Individual Response to Different Volumes of Resistance Training
Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes
The literature is not clear as to which training volume to employ during initial phases of resistance training programs to ensure optimal muscular adaptations. The purpose of this study is therefore to compare effects of strength training with low versus moderate volume on muscular function and hypertrophy in previously untrained, healthy individuals. Furthermore, the investigators will relate individual variation in responses to proxy markers of individual training state, such as baseline muscular function and muscle fiber type.
The study will include 25 women and 25 men and will consist of a 12-week resistance training protocol. Each study participant will act as their own control, performing both the low- (1-set) and the moderate-volume (3-sets) protocol, allocated to either the dominant or non-dominant leg, in a stratified and randomized fashion.
Primary outcome measures are thigh muscle cross section area and unilateral knee extension strength. Additionally, muscle fiber type composition will be evaluated as well as additional parameters of muscular function.
The primary hypothesis is that low-volume protocols will be beneficial for individuals with glycolytic muscle phenotypes, whereas the opposite will be true for individuals with more aerobic phenotypes.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lillehammer, Norway
- Lillehammer University College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy
- Non-smoking
- Able to tolerate resistance exercise training
Exclusion Criteria:
- Presence or history of cardiovascular, metabolic, endocrine or neuromuscular disease
- Diagnosed mental health disorder
- Intolerance to local anesthetic
- No experience with exercise training
- Performing regular resistance training (more than 1 session per week during last 12 months)
- Impaired strength/ neuromuscular function due to previous injury
- Recurrent pain in lower back, knee or shoulders
- Taking prescribed medication that may affect outcome of training intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm label 1-Set, 3-Set
12-week progressive strength training protocol of different volumes
|
Every study participant will complete 12 weeks of progressive strength training with one leg performing 1-set per exercise per session and the contralateral leg performing 3-sets per exercise per session.
Allocation of dominant/non-dominant leg to either 1- or 3-set protocol will be done in a stratified, randomized fashion (stratified with regard to sex and baseline strength).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thigh muscle cross-sectional area
Time Frame: Week 0 (baseline) and 12 (post training intervention)
|
Changes in muscle cross sectional area of each thigh from baseline to post intervention, assessed by MRI.
|
Week 0 (baseline) and 12 (post training intervention)
|
|
Unilateral knee-extension isometric strength
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in maximum knee extensor, isometric strength evaluated at 120° knee angle (180° fully extended).
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle strength
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in maximum isoinertial strength defined by one-repetition maximum in leg press, knee extension, knee flexion, and bench press.
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
|
Knee extensors and flexors force-velocity relationship
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in torque measured during maximal voluntary isokinetic contraction at 60°, 120° and 240° ∙ sec-1.
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
|
Blood hormonal profiles
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
|
Resting (week 0, 2 and 12) and acutely exercise-induced (week 2) hormonal profiles (testosterone, insulin-like growth factor 1, growth hormone and cortisol) determined in serum from venous blood samples.
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Muscle fiber cross-sectional area
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in muscle fiber cross-sectional area assessed by immunohistochemistry from muscle biopsy.
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Protein expression
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in relative abundance of contractile protein isoforms (myosin heavy chain).
Modification of proteins related to muscle hypertrophy in relation to an acute exercise session (assessed during week 2 of the intervention).
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Gene expression
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in gene expression related to skeletal muscle hypertrophy and structural phenotype measured in steady state conditions (biopsy sampled in resting conditions, week 0, 2 and 12) and in relation to acute exercise (biopsy sampled 1-h after strength exercise, week 2).
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition changes
Time Frame: Week 0 (baseline) and 12 (post training intervention)
|
Changes in body compositions (lean mass and fat mass) from prior intervention to after intervention assessed by dual x-ray absorptiometry scan.
|
Week 0 (baseline) and 12 (post training intervention)
|
|
Habitual physical activity
Time Frame: Week 0
|
Self-reported prior habitual physical activity assessed by questionnaire and interview before training intervention
|
Week 0
|
|
Daily nutrient intake
Time Frame: Week 6
|
Daily nutrient intake assessed by a 4-day food intake registration.
|
Week 6
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stian Ellefsen, PhD, Inland Norway University of Applied Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Trainsome 2014#002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on 12-week progressive strength training protocol
-
University of Illinois at Urbana-ChampaignAmerican Diabetes AssociationRecruiting
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Queen Fabiola Children's University Hospital; University GhentCompletedCerebral Palsy, SpasticBelgium
-
University of UtahCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Glostrup University Hospital, CopenhagenCompletedNeurological Diseases | Medical Diseases | Chronical Obstructive Lung DiseasesDenmark
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
Mayo ClinicRecruitingBlood Pressure | Lipid Profile | Fasting GlucoseUnited States
-
Hugo W. Moser Research Institute at Kennedy Krieger...National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Riphah International UniversityCompletedSpastic Cerebral PalsyPakistan
-
Habil HamdouniCompletedInflammation | Oxidative Stress | Hormones | Plasma VolumeTunisia